SCHEMBL12809273

SCHEMBL12809273

C#CC(O)CCc1cc2ccccc2s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.51
ASIC3 Q9UHC3 1/20 0.47
LOXL2 Q9Y4K0 1/20 0.47
AGXT P21549 1/20 0.44
ADRB2 P07550 1/20 0.44
ADRA1D P25100 2/20 0.38
MGLL Q99685 1/20 0.37
IDH1 O75874 1/20 0.36
CHRNA7 P36544 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
GLS O94925 1/20 0.36
BCL2L1 Q07817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661440 0.84 CYP2A6 (0.54) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL28394803 0.76 CYP2A6 (0.55) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL661546 0.73 CYP2A6 (0.71) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL14588797 0.72 AGXT (0.42) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL9852785 0.72 CYP2A6 (0.55) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL5323216 0.72 CYP2A6 (0.50) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL79169 0.70 CYP2A6 (0.67) CYP2A6ASIC3LOXL2AGXTADRB2
Hydrochloric Acid SCHEMBL28235220 0.70 CYP2A6 (0.61) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL12809120 0.70 CYP1A2 (0.45) CYP2A6
SCHEMBL23259460 0.70 CYP2A6 (0.60) CYP2A6ASIC3LOXL2AGXTADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814848-B9 2,3,4-SUBSTITUTED-CYCLOPENTANONES AS THERAPEUTIC AGENTS ALLERGAN INC (US) 2011-12-21 EP disclosed
EP-1814848-B1 2,3,4-SUBSTITUTED-CYCLOPENTANONES AS THERAPEUTIC AGENTS ALLERGAN INC (US) 2010-07-28 EP disclosed
US-7183324-B2 2,3,4-substituted cyclopentanones as therapeutic agents ALLERGAN, INC. (US) 2007-02-27 US disclosed
US-7183324-B2 2,3,4-substituted cyclopentanones as therapeutic agents ALLERGAN, INC. (US) 2007-02-27 US disclosed